SEARCH
Current Location:
>
> This Story

Forward Printable StoryPrint Comment

Never Miss a Story

Sign up for email alerts

 

More News Headlines

Robotic supported training helps chronic spinal patients recover

Medtronic Highlights New Data in JAMA Surgery Demonstrating Significant Cost Savings and Reduced Patient Hospital Stays Followin

At HIMSS15, Agfa HealthCare "Envisions the future of Care" as Enterprise Imaging becomes central to advancing value-based care Agfa HealthCare drives efficient access to patient-centric clinical data via multiple innovative advancements to its suites of technologies

Health Canada greenlights IMRIS ceiling-mounted intraoperative CT solution

Samsung and TeleHealth Services Announce Completion of New Patient Care Solution to Cut Costs of Interactive Patient Engagement

DEPUY SYNTHES COMPANIES ANNOUNCES EXCLUSIVE AGREEMENT WITH RADLINK TO HELP ADDRESS KEY CHALLENGES IN HIP REPLACEMENT

NEW MINIMALLY INVASIVE VASCULAR ACCESS SYSTEM DEMONSTRATES POSITIVE OUTCOMES IN DIALYSIS PATIENTS

GE Healthcare Building a Stronger Network in the Fight Against Cancer New Omnyx-Clarient alliance enables collaboration in the cancer diagnosis process, empowers personalized therapeutics

InterCommunity Cancer Centers to Enhance Coordinated Patient Care by Offering Comprehensive Services at One Single Location In its continued efforts to enhance the access and delivery of coordinated cancer care for local patients, InterCommunity Cancer Centers (ICCC) has announced plans to centralize its comprehensive services in order to provide them at one single location in Lady Lake beginning April 1st.

Amerinet Signs Healthcare GPO Contract with Radiology Protocols

Access Scientific Gets FDA Clearance for 4Fr Nanopuncture POWERWAND

Newly Improved Peripheral IV Catheter Is Blood-Drawable, Power-Injectable, and Can Deliver Therapy for Entire Length of Stay

SAN DIEGO -- Access Scientific, Inc. announced it has received FDA 510(k) clearance for the 4Fr Nanopuncture™ POWERWAND®. The unique peripheral IV catheter (technically a midline at 3.1 inches) is lighter and designed to provide smoother handling and even greater ease of insertion.

Story Continues Below Advertisement

ENTERPRISE-LEVEL INFORMATION SHARING. NEXT-LEVEL CARE from McKesson

As your health system grows McKesson keeps you one step ahead with solutions for the entire enterprise & your diagnostic imaging departments. Visit McKesson at HIMSS booth 2602. Click for more info or to schedule a HIMSS demo



The 4Fr Nanopuncture POWERWAND is, like the previously FDA-cleared 5Fr version, a power-injectable, peripheral IV catheter that is inserted using the proprietary Accelerated Seldinger Technique.

The POWERWAND can be used both for the administration of fluids/medications and for withdrawing blood for diagnostic tests. It is the first and only power-injectable peripheral IV (PIV) catheter capable of delivering continuous IV therapy for the patient's entire length of hospital stay. The device may be left in place for up to 29 days per its FDA clearance. It is also designed to be an integral part of any program to reduce central-line associated bloodstream infections (CLABSI).

The catheter has been well received by hospitals using it. "The 4Fr version gives the vascular access team more options. An extended-dwell catheter that can be placed both in the upper arm with ultrasound, or in the lower arm or forearm without using ultrasound, is the bridge we needed between the peripheral IV and the PICC. Sometimes with vascular access we need as many options as we can get," said Peter Hobday, RN, CCRN, CRNI, Director of the Vascular Access team at Brotman Medical Center, in Culver City, Calif.

The POWERWAND's versatility makes it the first and best choice for many patients, said Steve Bierman, M.D., president and CEO of Access Scientific.

"CDC Guidelines now say that patients whose IV therapy will likely exceed six days should have a midline or, if -- and only if - indicated, a central line," Dr. Bierman said. "Based on recent studies, this means that nearly 30% of hospitalized patients should have a POWERWAND."

In addition to allowing consistent blood draws, the catheter has a flow rate of 130 mL per minute -- making it by far the fastest-flowing peripheral line of its size. "This rapid flow rate capability translates into lives saved in the emergency department, OR and ICU," said Dr. Bierman.

The POWERWAND has several notable safety features:

* Alternative to central lines. Because it is not a central line, the catheter does not carry the same high risk of potentially fatal bloodstream infections. Midline catheters such as the 4Fr Nanopuncture POWERWAND have the lowest published bloodstream infection rate of all inpatient vascular access devices.

Continue reading Access Scientific Gets FDA Clearance for 4Fr Nanopuncture POWERWAND...
  Pages: 1 - 2 >>

Related:


Interested in Medical Industry News? Subscribe to DOTmed's weekly news email and always be informed. Click here, it takes just 30 seconds.

You Must Be Logged In To Post A Comment

Advertise
Increase Your
Brand Awareness
Auctions + Private Sales
Get The
Best Price
Buy Equipment/Parts
Find The
Lowest Price
Daily News
Read The
Latest News
Directory
Browse All
DOTmed Users
Ethics on DOTmed
View Our
Ethics Program
Gold Parts Vendor Program
Receive PH
Requests
Gold Service Dealer Program
Receive RFP/PS
Requests
Healthcare Providers
See all
HCP Tools
Jobs/Training
Find/Fill
A Job
Parts Hunter +EasyPay
Get Parts
Quotes
Recently Certified
View Recently
Certified Users
Recently Rated
View Recently
Certified Users
Rental Center
Rent Equipment
For Less
Sell Equipment/Parts
Get The
Most Money
Service Technicians Forum
Find Help
And Advice
Simple RFP
Get Equipment
Quotes
Virtual Trade Show
Find Service
For Equipment
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2015 DOTmed.com, Inc.
ALL RIGHTS RESERVED